đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study is being conducted to demonstrate the superiority in progression...
Status
Completed
Location
Multiple Locations
Start Date
2012-08
Trial ID
NCT01580228
Treatments Being Tested
To study the safety and side effects of Ofatumumab in the treatment of chro...
Status
Completed
Location
Mayo Clinic Cancer Center
Start Date
2012-11-14
Trial ID
NCT01680965
Treatments Being Tested
This study is being done to understand how to treat Mantle Cell Lymphoma (M...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center at Basking Ridge
Start Date
2011-09
Trial ID
NCT01437709
Treatments Being Tested
The goal of this clinical research study is to learn if ofatumumab can help...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2011-03
Trial ID
NCT01243190
Treatments Being Tested
This is a Phase II, single-arm study of ofatumumab investigating the safety...
Status
Completed
Location
Colorado Blood Cancer Institute
Start Date
2013-07
Trial ID
NCT01848145
Treatments Being Tested
To study the safety and efficacy of anti-CD20 blockade with ofatumumab in t...
Status
Completed
Location
UniversitÀtsklinikum Heidelberg
Start Date
2013-03
Trial ID
NCT01809847
Treatments Being Tested
The primary objective of the study is to evaluate the safety of idelalisib ...
Status
Completed
Location
Clearview Cancer Institute
Start Date
2010-03-25
Trial ID
NCT01088048
The primary objective of the study is to determine the efficacy, as measure...
Status
Completed
Location
Birmingham Hematology and Oncology Associates, LLC
Start Date
2010-05
Trial ID
NCT01108341
Treatments Being Tested
The purpose of this study was to confirm the clinical benefit observed in t...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-04-14
Trial ID
NCT01313689
Treatments Being Tested
A clinical study to evaluate a treatment with two drugs, named Ofatumumab a...
Status
Completed
Location
UniversitĂ degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia
Start Date
2015-10
Trial ID
NCT02388048
Treatments Being Tested